Efficacy and safety of atezolizumab plus bevacizumab as first-line therapy in unresectable Hepatocellular Carcinoma (uHCC) patients with Child-Pugh B compared with Child-Pugh A: A systematic review

MP148_abst

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

MP148_abst.pdf

https://luke.repo.nii.ac.jp/record/2000307/files/MP148_abst.pdf

application/pdf

ファイル	ライセンス
MP148_abst.pdf (121.0 kB) sha256 957ddbfeedaf661b53e67941d6e31d000f6035c180ce0c78f2d7a8052c657644

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays